(11bR)-4-Hydroxy-2,6-bis(3,4,5-trifluorophenyl)dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine 4-oxide

Catalog No. :
ACSSOA027
CAS No. :
861909-31-1
Molecular Formula :
C32H15F6O4P
Molecular Weight :
608.43

IUPAC Name:4-hydroxy-2,6-bis(3,4,5-trifluorophenyl)dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine 4-oxide

(11bR)-4-Hydroxy-2,6-bis(3,4,5-trifluorophenyl)dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine 4-oxide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(11bR)-4-Hydroxy-2,6-bis(3,4,5-trifluorophenyl)dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine 4-oxide
IUPAC Name4-hydroxy-2,6-bis(3,4,5-trifluorophenyl)dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine 4-oxide
Molecular FormulaC32H15F6O4P
Molecular Weight608.43
SMILESO=P1(OC2=C(C3=CC(F)=C(C(F)=C3)F)C=C4C=CC=CC4=C2C5=C(C(C6=CC(F)=C(F)C(F)=C6)=CC7=C5C=CC=C7)O1)O
InChI KeyGRYYFWFSBJUIPR-UHFFFAOYSA-N
Synonym(11bR)-4-Hydroxy-2,6-bis(3,4,5-trifluorophenyl)dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine 4-oxide;(11bR)-4-Hydroxy-2,6-bis(2,4,6-trifluorophenyl)-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin;Dinaphtho[2,1-d:1′,2′-f][1,3,2]dioxaphosphepin, 4-hydroxy-2,6-bis(3,4,5-trifluorophenyl)-, 4-oxide, (11bR)-
CAS No.861909-31-1

Synthetic Route by SureRoute

1. ACSSOA027 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACGUSM613 route compound structure diagram
    ACGUSM613143418-49-9 In Stock
  4. Then
  5. ACSSOA027 route product structure diagram
    ACSSOA027861909-31-1
Inquiry

2. ACSSOA027 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACSSOA027 route product structure diagram
    ACSSOA027861909-31-1
Inquiry

Comments (0)